This article is more than 5 years old. Information may no longer be current.

Camber announces launch of generic Nexium delayed-release capsules

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Camber Pharmaceuticals announced the launch of esomeprazole magnesium delayed-release capsules, a generic version of AstraZeneca’s Nexium, for the treatment of heartburn, GERD, stomach ulcers and esophageal damage, according to a press release.

“Esomeprazole represents as a significant product in the growth of our organization,” Kon Ostaficiuk, president of Camber, said in the press release. “Our parent company, Hetero Labs Limited, has received the final approval for esomeprazole [abbreviated new drug application] from the U.S. FDA. Hetero Labs Limited has invested in the technology used to manufacture this challenging product and the results are reflected in the scale of our capacities.”

The new generic drug is available in 20-mg and 40-mg doses and in 30-, 90- and 1000-count bottles, according to the press release.

“We are very happy to extend one more affordable treatment option to the patients in [the] U.S.,” Ostaficiuk said in the press release. “Our product pipeline continues to be impressive and it shows Camber’s commitment to provide affordable medications in a wide variety of formulations and therapies in [the] U.S.”

Disclosures: Ostaficiuk reports he is an employee of Camber Pharmaceuticals.